Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Relates to program eligibility for plans comparable to Medicare part D; provides for analysis of health plans by the department of health to determine whether such health plans meet or exceed the Medicare part D standard; requires the department of health, in consultation with the department of financial services, to notify prescription drug insurers of the provisions of this act.
Introduced
Jan 8, 2025
Last Action
Feb 4, 2026
Session
NY 2025-2026
Sponsors
1 primary · 7 co
REPORTED AND COMMITTED TO FINANCE
DIED IN ASSEMBLY
REFERRED TO HEALTH
RETURNED TO SENATE
PASSED SENATE
DELIVERED TO ASSEMBLY
REFERRED TO AGING
AMENDED ON THIRD READING (T) 355A
ADVANCED TO THIRD READING
2ND REPORT CAL.
1ST REPORT CAL.743
REPORTED AND COMMITTED TO FINANCE
REFERRED TO HEALTH
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
REPORTED AND COMMITTED TO FINANCE